Genistein as antioxidant and antibrowning agents in in vivo and in vitro: A review

Biomedicine and Pharmacotherapy

Volumn 82, Issue , 2016, Pages 379-392

  Rahman Mazumder, Md Anisur ^a,b   Hongsprabhas, Parichat ^b  

^a BANGLADESH AGRICULTURAL UNIVERSITY   (Bangladesh)

^b KASETSART UNIVERSITY   (Thailand)

Author keywords

Antibrowning; Anticancer; Antioxidant; Genistein; Maillard reaction

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ANTINEOPLASTIC AGENT; ANTIOXIDANT; BOVINE SERUM ALBUMIN; CHELATING AGENT; GENISTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; ISOFLAVONE DERIVATIVE; ORNITHINE DECARBOXYLASE;

AGING; BINDING AFFINITY; BINDING SITE; CANCER CELL; DNA ADDUCT; DRUG BIOAVAILABILITY; ENZYME ACTIVITY; FLUORESCENCE; GLYCATION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; RADIATION; REVIEW; SKIN CARCINOGENESIS; ULTRAVIOLET RADIATION; ANIMAL; BIOAVAILABILITY; CHEMISTRY; DRUG EFFECTS; METABOLISM;

ANIMALS; ANTIOXIDANTS; BIOLOGICAL AVAILABILITY; GENISTEIN; HUMANS; MAILLARD REACTION; SERUM ALBUMIN, BOVINE;

EID: 84969961760     PISSN: 07533322     EISSN: 19506007     Source Type: Journal    
DOI: 10.1016/j.biopha.2016.05.023     Document Type: Review

References (125)

1. Romani A., Vignolini P., Galardi P., Aroldi C., Vazzana C., Heimler D. Polyphenolic content in different plant parts of soy cultivars grown under natural conditions. J. Agric. Food Chem. 2003, 51:5301-5306.
2. Kimira M., Arai Y., Shimoi K., Watanabe S. Japanese intake of flavonoids and isoflavonoids from foods. J.Epidemiol. 1998, 8:168-175.
3. Chen Z., Zheng W., Cluster L.J., Dai Q., Shu X.Q., Jin F., Franke A.A. Usual dietary consumption of soy foods and its correlation with the excretion rate of isoflavonoids in overnight urine samples among Chinese women in Shanghai. Nutr. Cancer. 1999, 33:82-87.
4. Van Erp-Baart M.A., Brandts H.A., Kiely M., Mullinga A., Turrini A., Sermonetta C., Kilkkinen A., Valsta L.M. Isoflavone intake in four different European countries: the VENUS approach. Br. J. Nutr. 2003, 89:S25-S30.
5. Klein M.A., Nahin R.L., Messina M.J., Rader J.I., Thompson L.U., Badger T.M., Dwyer J.T., Kim Y.S., Pontzer C.H., Starke-Reed P.E., Weaver C.M. Guidance from an NIH workshop on designing implementing, and reporting clinical studies of soy interventions. J. Nutr. 2010, 140:1192S-1204S.
6. Mortensen A., Kulling S.E., Schwartz H., Rowland I., Ruefer C.E., Rimbach G., Cassidy A., Magee P., Millar J., Hall W.L., Birkved F.K., Sorensen I.K., Sontag G. Analytical and compositional aspects of isoflavones in food and their biological effects. Mol. Nutr. Food Res. 2009, 53:S266-S309.
7. Doll R., Peto R. The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J. Natl. Cancer Inst. 1981, 66:1191-1308.
8. Setchell K.D.R., Cassidy A. Dietary isoflavones: biological effects and relevance to human health. J.Nutr 1999, 129:758S-767S.
9. Cassidy A., Albertazzi P., Nielsen I.L., Hall W., Williamson G., Tetens I., Atkins S., Cross H., Manios Y., Wolk A., Steiner C., Branca F. Critical review of health effects of soyabean phyto-oestrogens in post-menopausal women. Proc. Nutr. Soc. 2006, 65:76-92.
10. Liu K. Soybeans: Chemistry, Technology and Utilization 1997, Chapman and Hall, New York.
11. Erickson D.R. Practical Handbook of Soybean Processing and Utilization 1995, AOCs, USA.
12. Rostagno M.A., Palma M., Barroso C.G. Pressurized liquid extraction of isoflavones from soybeans. Anal. Chimica Acta. 2004, 522:169-177.
13. Lee S.W., Lee J.H. Effects of oven-drying roasting, and explosive puffing process on isoflavone distribution in soybeans. Food Chem. 2009, 112:316-320.
14. Adlercreutz C.H.T. Western diet and Western diseases: some hormonal and biochemical mechanisms and associations. Scandinavian J. Clin. Lab. Invest. 1990, 50:3-23.
15. Yu H., Harris R., Gao Y., Wynder E. Comparative epidemiology of cancers of the colon, rectum, prostate and breast in Shanghai, China versus the United States. Int. J. Epidemiol. 1991, 20:76-81.
16. Rose D., Boyar A., Wynder E. International comparisons of mortality rates for cancer of the breast, ovary, prostate and colon, and per capita food consumption. Cancer 1986, 58:2363-2371.
17. Clarkson T. Soy phytoestrogens: what will be their role in postmenopausal hormone replacement therapy?. Menopause: J. North Am. Menopause Soc. 2000, 7:71-75.
18. Adlercreutz C.H.T., Hamalainen H.E., Gorbachv S., Goldin B. Dietary phytoestrogens and the menopause in Japan. Lancet 1992, 339:1233.
19. Armstrong B., Doll R. Environmental factors and cancer incidence and mortality in different countries, with specific reference to dietary practices. Int. J. Cancer 1975, 15:617-631.
20. Wilcox J.N., Blumenthal B.F. Thrombotic mechanism in atherosclerosis: potential impacts of soy proteins. J.Nutr. 1995, 125:624S-630S.
21. Albertazzi P., Pansini F., Bottazzi M., Bonaccorsi G., De Aloysio D., Morton M.S. Dietary soy supplementation and phytoestrogen levels. Obstet. Gynecol. 1999, 94:229-231.
22. Albertazzi P., Steel S.A., Clifford E., Bottazzi M. Attitudes towards and use of dietary supplementation in a sample of postmenopausal women. Climacteric 2002, 5:374-382.
23. Yamaguchi M., Goa Y.H. Genistein inhibits bone loss. Biochem. Pharmacol. 1998, 55:71-76.
24. Adlercreutz C.H.T., Goldin B.R., Gorbach S.L., Höckerstedt K.A.V., Watanabe S., Hämäläinen E.K., Markkanen M.H., Mäkelä T.H.W., Adahälä K.T., Hase T.A., Fotsis T. Soybean phytoestrogen intake and cancer risk. J.Nutr. 1995, 125:S757-S770.
25. Tham D.M. Potential health benefits of dietary phytoestrogens: a review of the clinical, epidemiological, and mechanistic evidence. J. Clin. Endocrinol. Metab. 1998, 83:2223-2235.
26. Messina M., Barnes S. The role of soy products in reducing risk of cancer. J. Natl. Cancer Inst. 1991, 83:541-546.
27. Messina M., Persky V., Setchell K., Barnes S. Soy intake and cancer risk: a review of the in vitro and in vivo data. Nutr. Cancer. 1994, 21:113-131.
28. Kerry N., Abbey M. The isoflavone genistein inhibits copper and peroxyl radical mediated low density lipoprotein oxidation in vitro. Atheroscleros 1998, 140:341-347.
29. Wilson T., March H., Ban W.J., Hou Y., Adler S., Mayers C.Y., Winters T.A., Maher M.A. Antioxidant effects of phyto-and synthetic-estrogens on cupric ion induced oxidation of human low-density lipoproteins in vitro. Life Sci. 2002, 70:2287-2297.
30. Wet L.G., Birac P.M., Pratt D.E. Separation of the isomeric isoflavones from soybeans by high-performance liquid chromatograph. J.Chromatogr. 1978, 150:266-268.
31. Batterham T.J., Hart N.K., Lamberton J.A. Metabolism of oestrogenic isoflavones in sheep. Nature 1965, 4983:509.
32. Murray P.A., Farmakalidis E., Johnson L.D. Isoflavone content of soya-based laboratory animal diets. Food Chem. Toxicol. 1992, 20:315-317.
33. Livinston A.L. Forage plant estrogens. J. Toxicol. Environ. Health 1978, 4:301-324.
34. Shemesh M., Lindner H.R., Ayalaoan N. Affinity of rabbit uterine oestradiol receptor for phyto-oestrogens and its use in a competitive protein-binding radioassay for plasma coumestrol. J. Reprod. Fertil. 1972, 29:1-9.
35. Tanaka N., Yonekura H., Yamagishi S., Fujimori H., Yamamoto Y., Yamamoto H. The receptor for advanced glycation end products is induced by the glycation products themselves and tumor necrosis factor-alpha through nuclear factor-κB, and by 17 β-estradiol through Sp-1 in human vascular endothelial cells. J. Biol. Chem. 2000, 275:25781-25790.
36. Thomas M.C., Baynes J.W., Thorpe S.R., Cooper M.E. The role of AGEs and AGE inhibitors in diabetic cardiovascular disease. Curr. Drug Target. 2005, 6:453-474.
37. Price D.L., Rhett P.M., Thorpe S.R., Baynes J.W. Chelating activity of advanced glycation end-product inhibitor. J. Biol. Chem. 2001, 276:48967-48972.
38. Webster J., Urban C., Berbaum K., Loske C., Alpar A., Gartner U., de Arriba S.G., Arendt T., Munch G. The carbonyl scavengers aminoguanidine and tenilsetam protect against the neurotoxic effects of methylglyoxal. Neurotoxic. Res. 2005, 7:95-101.
39. Blatnik M., Frizzell N., Thorpe S.R., Baynes J.W. Inactivation of glyceraldehyde-3-phosphate dehydrogenase by fumarate in diabetes: formation of S-(2-succinyl) cysteine, a novel chemical modification of protein and possible biomarker of mitochondrial stress. Diabetes 1998, 57:41-49.
40. Beisswenger P., Ruggiero-Lopez D. Metformin inhibition of glycation processes. Diabetes Metab. 2003, 29:6S95-103.
41. Beisswenger P.J., Howell S.K., Touchette A.D., Lal S., Szwergold B.S. Metformin reduces systemic methylglyoxal levels in type 2 diabetes. Diabetes 1999, 48:198-202.
42. Nagaraj R.H., Sarkar P., Mally A., Biemel K.M., Lederer M.O., Padayatti P.S. Effect of pyridoxamine on chemical modification of proteins by carbonyls in diabetic rats: characterization of a major product from the reaction of pyridoxamine and methylglyoxal. Arch. Biochem. Biophys. 2002, 40:110-119.
43. Voziyan P.A., Metz T.O., Baynes J.W., Hudson B.G. A post-Amadori inhibitor pyridoxamine also inhibits chemical modification of proteins by scavenging carbonyl intermediates of carbohydrate and lipid degradation. J. Biol. Chem. 2002, 277:3397-3403.
44. Thornalley P.J. Use of aminoguanidine (Pimagedine) to prevent the formation of advanced glycation end products. Arch. Biochem. Biophys. 2003, 419:31-40.
45. Colahan-Sederstrom P.M., Peterson D.G. Inhibition of key aroma compound generated during ultra-high temperature processing of bovine milk via epicatechin addition. J. Agric. Food Chem. 2005, 53:398-402.
46. Lv L., Shao X., Chen H., Ho H.C.-T., Sang S. Genistein inhibits advanced glycation end product formation by trapping methylglyoxal. Chem. Res. Toxicol. 2011, 24:579-586.
47. Manach C., Williamson G., Morand C., Scalbert A., Rémésy C. Bioavailabilty and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am. J. Clin. Nutr. 2005, 81(Suppl):230S-242S.
48. Setchell K.D.R., Brown N.M., Desai P., Zimmet-Nechemias L., Wolfe B.E., Brashear W.T., Kirschner A.S., Cassidy A., Heubi J.E. Bioavailability of pure isoflavones in healthy humans and analysis of commercial soy isoflavone supplements. J.Nutr 2001, 131:1362S-1375S.
49. Zubik L., Meydani M. Bioavailability of soybean isoflavones from aglycone and glucoside forms in American wome. Am. J. Clin. Nutr. 2003, 77:1459-1465.
50. Setchell K.D.R. Phytoestrogens: the biochemistry, physiology, and implications for human health of soy isoflavones. Am. J. Clin. Nutr. 1998, 68:1333S-1346S.
51. Wong C.-K., Keung W.M. Daidzein sulfoconjugates are potent inhibitors of sterol sulfatase (EC 3.1.6.2). Biochem. Biophys. Res. Commun. 1997, 233:579-583.
52. Hollman P.C.H., de Vries J.H.M., van Leeuwen S.D., Mengelers M.J.B., Katan M.B. Absorption of dietary quercetin glycosides and quercetin in healthy ileostomy volunteers. Am. J. Clin. Nutr. 1995, 62:1276-1282.
53. Piskula M.K., Yamakoshi J., Iwai Y. Daidzein and genistein but not their glucosides are absorbed from the rat stomach. FEBS Lett. 1999, 447:287-291.
54. Izumi T., Piskula M.K., Osawa S., Obata A., Tobe K., Saito M., Kataoka S., Kubota Y., Kikuchi M. Soy isoflavone aglycones are absorbed faster and in higher amounts than their glycosides in humans. J.Nutr. 2000, 130:1695-1699.
55. Steensma A. Bioavailability of Genistein and Its Glycoside Genistin 2000, Wageningen University, Wageningen.
56. Cederroth C.R., Zimmermann C., Nef S. Soy, phytoestrogens and their impact on reproductive health. Mol. Cell. Endocrinol. 2012, 355:192-200.
57. Heinonen S.M., Hoikkala A., Wahala K., Adlercreutz H. Metabolism of the soy isoflavones daidzein: genistein and glycitein in human subjects. Identification of new metabolites having an intact isoflavonoid skeleton. J. Steroid Biochem. Mol. Biol. 2003, 87:285-299.
58. Kulling S.E., Honig D.M., Metzler M. Oxidative metabolism of the soy isoflavones daidzein and genistein in humans in vitro and in vivo. J. Agric. Food Chem. 2001, 49:3024.
59. Tomonaga T., Mine T., Kojima I., Taira M., Hayashi H., Isono K. Isoflavonoids genistein, psi-tectorigenin, and orobol, increase cytoplasmic free calcium in isolated rat hepatocytes. Biochem. Biophy. Res. Commun. 1992, 182:894-899.
60. Yamashita Y., Kawada S., Nakano H. Related Induction of mammalian topoisomerase II dependent DNA cleavage by nonintercalative flavonoids, genistein and orobol. Biochem. Pharmacol. 1990, 39:737-744.
61. Gyorgy P., Murata K., Ikehata H. Antioxidants isolated from fermented soybeans (tempeh). Nature 1964, 203:870-872.
62. Pratt D.E., Di Pietro C., Porter W.L., Giffee J.W. Phenolic antioxidants of soy protein hydrolyzates. J.Food Sci. 1981, 47:24-25.
63. Jha H.C., von Recklinghausen G., Zilliken F. Inhibition of in vitro microsomal lipid peroxidation by isoflavonoids. Biochem. Pharmacol. 1985, 34:1367-1369.
64. Lundh T.J.O., Lundgren B.O. Uncoupling and inhibition of the respiratory chain in rat liver mitochondria by some naturally occurring estrogens and their metabolites. J. Agric. Food Chem. 1991, 39:736-739.
65. Barnes S. Effects of genistein in in vivo and in vitro models of cancer growth. J.Nutr. 1995, 125:7775-7835.
66. Barnes S., Peterson G. Biochemical targets of the isoflavone genistein in tumor cell lines. Proc. Soc. Exp. Med. Biol. 1994, 208:103-108.
67. Davis N.J., Kucuk O., Sarkar F.H. Genistein inhibits NF-kB activation in prostate cancer cells. Nutr. Cancer 1999, 35:167-174.
68. Davis N.J., Kucuk O., Djuric Z., Sarkar F.H. Soy isoflavone supplementation in healthy men prevents NF-κB activation by TNF-α in blood lymphocytes. Free Radic. Biol. Med. 2001, 30:1293-1302.
69. Okura A., Arakawa H., Oka H., Yoshinari T., Monden Y. Effect of genistein on topoisomerase activity and on the growth of [VAL 12] Ha-ras-transformed NIH 3T3 cells. Biochem. Biophys. Res. Commun. 1988, 157:183-189.
70. Zwiller J., Sassone-Corsi P., Kakazu K., Boyton A.L. Inhibition of PDGF-induced c-jun and c-fos expression by a tyrosine protein kinase inhibitor. Oncogene 1991, 6:219-221.
71. Dean N.M., Kanemitsu M., Boynton A.L. Effects of the tyrosine kinase inhibitor genistein on DNA synthesis and phospholipid-derived second messenger generation in mouse 10T1/2 fibroblasts and rat liver T51B cells. Biochem. Biophys. Res. Commun. 1989, 165:795-801.
72. Altruru D., Jackson T.M., Altruru S. Genistein, a selective protein tyrosine kinase inhibitor, inhibits interleukin-2 and leukotriene B4 production form human mononuclear cells. Clin. Immunol. Immuopath. 1991, 59:379-387.
73. Glaser K.B., Sung A., Bauer J., Weichman B.M. Regulation of eicosanoid biosynthesis in the macrophage. Biochem. Pharmacol. 1993, 45:711-721.
74. Hodgson J.M., Croft K.D., Puddey I.B., Mori T.A., Beilin L.J. Soybean isoflavonoids and their metabolic products inhibit in vitro lipoprotein oxidation is serum. Nutr. Biochem. 1996, 7:664-669.
75. Ruiz-Larrea M.B., Mohan A.R., Pagana G., Miller N.J., Bolwell G.P., Rice-Evans C.A. Antioxidant activity of phytoestrogenic isoflavones. Free Radic. Res. 1997, 26:63-70.
76. Wei H., Bowen R., Zhang X., Lebwohl M. Isoflavone genistein inhibits the initiation and promotion of two-stage skin carcinogenesis in mice. Carcinogen 1988, 19(8):1509-1514.
77. Record I.R., Dreosti I.E., McInerney J.K. The antioxidant activity of genistein in vitro. J. Nutr. Biochem. 1995, 6:481-485.
78. Wei H., Cai R.Q., Barnes S., Wang Y. Antioxidant and antipromotional effects of the soybean isoflavone genistein. Proc. Soc. Exp. Biol. Med. 1995, 208(1):124-130.
79. USDA-Iowa State University Isoflavones Database. United States Department of Agriculture [Web page]. March 15, 2002. Available at: . (accessed 14.04.16.). http://www.ars.usda.gov/SP2UserFiles/Place/80400525/Data/isoflav/isoflav1-4.pdf.
80. Foti P., Erba D., Riso P., Spadafranca A., Criscuoli F., Testolin G. Comparison between daidzein and genistein antioxidant activity in primary and cancer lymphocytes. Archives Biochem. Biophys. 2005, 433:421-427.
81. Davis J.N., Kucuk O., Sarkar F.H. Genistein inhibits NF-kappa B activation in prostate cancer cells. Nutr. Cancer. 1999, 35:167-174.
82. Raffoul J.J., Wang Y., Kucuk O., Forman J.D., Sarkar F.H., Hillman G.G. Genistein inhibits radiation-induced activation of NF-κB in prostate cancer cells promoting apoptosis and G2/M cell cycle arrest. BMC Cancer. 2006, 6:106-117.
83. Sarkar F.H., Li Y. The role of isoflavones in cancer chemoprevention, Front. Biosci 2004, 9:2714-2724.
84. Li Y., Ellis K.L., Ali S., El-Rayes B., Nedeljkovic-Kurepa A., Kucuk O., Philip P.A., Sarkar F.H. Apoptosis-inducing effect of chemotherapeutic agents is potentiated by soy isoflavone genistein, a natural inhibitor of NF-κB in BxPC-3 pancreatic cancer cell line. Pancreas 2004, 28:e90-e95.
85. Ozeki M., Tamae D., Hou D.X., Wang T., Lebon T., Spitz D.R., Li J.J. Response of cyclin B1 to ionizing radiation: regulation by NF-kappa B and mitochondrial antioxidant enzyme MnSOD. Anticancer Res. 2004, 24:2657-2663.
86. Gong L., Li Y., Nedeljkovic-Kurepa A., Sarkar F.H. Inactivation of NF-κB by genistein is mediated via Akt signaling pathway in breast cancer cells. Oncogene 2003, 22:4702-4709.
87. Banerjee1 S., Zhang1 Y., Wang1 Z., Che1 M., Chiao P.J., Abbruzzese J.L., Sarkar F.H. In vitro and in vivo molecular evidence of genistein action in augmenting the efficacy of cisplatin in pancreatic cancer. Int. J. Cancer. 2006, 120:906-917.
88. Li Y., Ahmed F., Ali S., Philip P.A., Kucuk O., Sarkar F.H. Inactivation of nuclear factor κB by soy isoflavone genistein contributes to increased apoptosis induced by chemotherapeutic agents in human cancer cells. Cancer Res. 2005, 65:6934-6942.
89. Li Y., Ellis K.L., Ali S., El-Rayes B.F., Nedeljkovic-Kurepa A., Kucuk O., Philip P.A., Sarkar F.H. Apoptosis-inducing effect of chemotherapeutic agents is potentiated by soy isoflavone genistein, a natural inhibitor of NF-κB in BxPC-3 pancreatic cancer cell line. Pancreas 2004, 28:e90-e95.
90. Arlt A., Vorndamm J., Breitenbroich M., Folsch U.R., Kalthoff H., Schmidt W.E., Schafer H. Inhibition of NF-κB sensitizes human pancreatic carcinoma cells to apoptosis induced by etoposide (VP16) or doxorubicin. Oncogene 2001, 20:859-868.
91. Record I.R., Broadbent J.L., King R.A., Dreosti I.E., Head R.J., Tonkin A.L. Genistein inhibits growth of B16 melanoma cells in vivo and in vitro and promotes differentiation in vitro. Int. J. Cancer. 1997, 72:860-864.
92. Traganos F., Ardelt B., Halko N., Bruno S., Darzynkiewicz Z. Effects of genistein on the growth and cell cycle progression of normal human lymphocytes and human leukemic MOLT-4 and HL-60 cells. Cancer Res. 1992, 52:6200-6208.
93. Guo T.L., McCay J.A., Zhang L.X., Brown R.D., You L., Karrow N.A., Germolec D.R., White K.L. Genistein modulates immune responses and increases host resistance to B16F10 tumor in adult female B6C3F1 mice. J. Nutr. 2001, 31:3251-3258.
94. 14C] genistein in the rat: gender-related differences, potential mechanisms of biological action, and implications for human health. Toxicol. Appl. Pharmacol. 2000, 164:206-215.
95. Stahl S., Chun T.Y., Gray W.G. Phytoestrogens act as estrogen agonists in an estrogen-responsive pituitary cell line. Toxicol. Appl. Pharmacol. 1998, 152:41-48.
96. Makela S.I., Pylkkanen L.H., Santti R.S., Adlercreutz H. Dietary soybean may be antiestrogenic in male mice. J.Nutr. 1995, 125:437-445.
97. Scholar E.M., Toews M.L. Inhibition of invasion of murine mammary carcinoma cells by the tyrosine kinase inhibitor genistein. Cancer Lett. 1994, 87:159-162.
98. Yellayi S., Zakroczymski M.A., Selvaraj V., Valli V.E., Ghanta V., Helferich W.G., Cooke P.S. The phytoestrogen genistein suppresses cell-mediated immunity in mice. J. Endocrinol. 2003, 176:267-274.
99. Yellayi S., Naaz A., Szewczykowski M.A., Sato T., Woods J.A., Chang J., Segre M., Allred C.D., Helferich W.G., Cooke P.S. The phytoestrogen genistein induces thymic and immune changes: a human health concern?. Proc. Natl. Acad. Sci. 2002, 99:7616-7621.
100. Holmdahl R., Jansson L. Estrogen-induced suppression of collagen arthritis. III. Adult thymectomy does not affect the course of arthritis or the estrogen-mediated suppression of T-cell immunity. Brain Behav. Immum. 1998, 2:123-132.
101. Hoek A., van Kasteren Y., de Haan-Meulman M., Hooijkaas H., Schoemaker J., Drexhage H.A. Analysis of peripheral blood lymphocyte subsets NK cells, and delayed type hypersensitivity skin tests in patients with premature ovarian failure. Am. J. Reprod. Immun. Microb. 1995, 33:495-502.
102. Salem M.L., Matsuzaki G., Kishihara K., Madkour G.A., Nomoto K. Beta-estradiol suppresses T cell-mediated delayed-type hypersensitivity through suppression of antigen-presenting cell function and Th1 induction. Int. Arch. Allergy Appl. Immun. 2000, 121:161-169.
103. O'Connor T.P., Liesen D.A., Mann P.C., Rolando L., Banz W.J. A high isoflavone soy protein diet and intravenous genistein delay rejection of rat cardiac allografts. J.Nutr 2002, 132:2283-2287.
104. Kuiper G.G., Lemmen J.G., Carlsson B., Corton J.C., Safe S.H., van der Saag P.T., van der Burg B., Gustafsson J.A. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinolo 1998, 139:4252-4263.
105. Whitten P.L., Patisaul H.B. Cross-species and interassay comparisons of phytoestrogen action. Environ. Health Perspect. 2001, 109(Suppl 1):5-20.
106. 1,2. J. Nutr. 2016, 136(3):704-708.
107. Curran E.M., Judy B.M., Newton L.G., Lubahn D.B., Rottinghaus G.E., Macdonald R.S., Franklin C., Estes D.M. Dietary soy phytoestrogens and ERα signaling modulate interferon gamma production in response to bacterial infection. Clin. Exp. Immunol. 2004, 135:219-225.
108. Calemine J., Zalenka J., Karpuzoglu-Sahin E., Ward D.L., Lengi A., Ahmed S.A. The immune system of geriatric mice is modulated by estrogenic endocrine disruptors (diethylstilbestrol, α-zearalanol, and genistein): effects on interferon gamma. Toxicology 2003, 194:115-128.
109. Selvaraj V., Bunick D., Finnigan-Bunick C., Johnson R.W., Wang H., Liu L., Cooke P.S. Gene expression profiling of 17-β-estradiol and genistein effects on mouse thymus. Toxicol.Sci. 2005, 87(1):97-112.
110. Patel R.P., Boersma B.J., Crawford J.H., Hogg N., Kirk M., Kalyanaraman B., Parks D.A., Barnes S., Darley-Usmar V. Antioxidant mechanisms of isoflavones in lipid systems: paradoxical effects of peroxyl radical scavenging. Free Radic. Biol. Med. 2001, 31:1570-1581.
111. Arora A., Nair M.G., Strasburg G.M. Antioxidant activities of isoflavones and their biological metabolites in a liposomal system. Arch. Biochem. Biophys. 1998, 356:133-141.
112. Ferretti G., Bacchetti T., Menanno F., Curatola G. Effect of genistein against copper-induced lipid peroxidation of human high density lipoproteins (HDL). Atheroscleros 2004, 172:55-61.
113. Ferretti G., Taus M., Dousset N., Solera M.L., Valdiguié P., Curatola G. Physico chemical properties of copper oxidized high density lipoprotein: a fluorescence study. Biochem. Mol. Biol. Int. 1993, 30(4):713-719.
114. Dousset N., Ferretti G., Taus M., Valdiguie P., Curatola G. Fluorescence analysis of lipoprotein peroxidation, Methods. Enzymol 1994, 233:459-469.
115. Zhao J., Ren F. Influence of hydroxylation and glycosylation in ring A of soybean isoflavone on interaction with BSA. Spectrochim. Acta Part A 2009, 72:682-685.
116. Lakowicz J.R. Principles of Fluorescence Spectroscopy 1999, Kluwer, New York. second ed.
117. Cao H., Liu Q., Shi J., Xiao J.B., Xu M. Comparing the affinities of flavonoid isomers with protein by fluorescence spectroscopy. Anal. Lett. 2008, 41:521-532.
118. He Y., Wang Y.W., Tang L.F., Liu H., Chen W., Zheng Z.L., Zou G.L. Binding of puerarin to human serum albumin: a spectroscopic analysis and molecular docking. J.Fluoresc. 2007, 18:433-442.
119. Hodge J.E. Dehydrated foods, chemistry of browning reactions in model systems. J. Agric. Food Chem. 1953, 1:928-943.
120. Weenen H. Reactive intermediates and carbohydrate fragmentation in Maillard chemistry. Food Chem. 1988, 6:393-401.
121. Weenen H., Tjan S.B. 3-Deoxyhexosone as flavor precursor. Trends in Flavor Research 1994, 303-327. Elsevier, New York. H. Maarse, D.G. van der Heij (Eds.).
122. Biemel K.M., Lederer M.O. Site-specific quantitative evaluation of the protein glycation product N6-(2,3-dihydroxy-5,6-dioxohexyl)-L-lysinate by LC-(ESI)-MS peptide mapping. Evidence for its key role in AGE formation. Bioconjugate Chem. 2003, 14:619-628.
123. Kokkinidou S., Peterson D.G. Response surface methodology as optimization strategy for reduction of reactive carbonyl species in heat processed foods by means of phenolic chemistry. Food Funct. 2013, 4(7):1093-1104.
124. Davies C.G.A., Netto F.M., Glassenap N., Gallaher C.M., Labuza T.P., Gallaher D.D. Indication of the Maillard reaction during storage of protein isolates. J. Agric. Food Chem. 1998, 46:2483-2489.
125. Bitter S. When quinones meet amino acids: chemical, physical and biological consequences. Amino acid. 2006, 30:205-224.